Santiago Delgado-Tirado, MD, MSc, a research fellow under the mentorship ofJoseph Arboleda-Velasquez, MD, PhD, and Leo Kim, MD, PhD, received the Alfonso Martin Escudero Foundation Fellowship. This fellowship, which is in the amount of $88,500 over two years beginning in January 2018, was given for his project, "Runx1 inhibition as therapeutic strategy for aberrant angiogenesis in eye diseases."
Dr. Delgado-Tirado earned his MD and MSc in Vision Research from the University of Valladolid in Spain, where he is currently completing his PhD in Visual Sciences. He performed his Ophthalmology residency at the Clinic Hospital of Valladolid, and has been an Instructor for the Retina Research Group at the Applied Ophthalmobiology Institute at the University of Valladolid since 2013. He co-authored a study that received the Medical Research in Retina Award from the Spanish Society of Retina and Vitreous, Retinaplus+ Foundation, and Thea Laboratories in 2016. He joined Schepens Eye Research Institute of Mass. Eye and Ear in July 2017. His research focuses on angiogenesis in retinal diseases, retinal detachment and proliferative vitreoretinopathy.
The Alfonso Martín Escudero Foundation was created in 1957 to provide support to advance the training of researchers who focus on the natural sciences. They particularly focus on projects that may lead to the improved prosperity of Spain and well-being of Spanish people. Learn more about the foundation here.